Taken together, our integrated genetic and functional analysis of multi-ethnic GWAS, eQTL and TF binding data suggests a model whereby rs662463 predisposes to BCP-ALL by regulating CDKN2B expression through CEBPB signalling. This evidence concerns the gene CDKN2B and acute lymphoblastic leukemia.